Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03103646 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women
A Phase 1 study, sponsored by H. Lundbeck A/S.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT03103646 is a Phase 1 study that has completed, run by H. Lundbeck A/S. The registered enrollment target is 22 participants.
The verdict
NCT03103646, a Phase 1 study, has completed, sponsored by H. Lundbeck A/S.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study will investigate the effect of multiple doses of the strong P450 enzyme inhibitor itraconazole on the pharmacokinetics of Lu AF35700 in healthy subjects.
Interventions
- DRUG Lu AF35700
- DRUG Itraconazole (200 mg)
- DRUG Itraconazole (300 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-03-28 |
| Est. Completion | 2019-07-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03103646
The ClinicalTrials.gov registry entry for NCT03103646 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lu AF35700 is the first listed.
NCT03103646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03103646 about?
NCT03103646 is a clinical study titled "Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women". This study will investigate the effect of multiple doses of the strong P450 enzyme inhibitor itraconazole on the pharmacokinetics of Lu AF35700 in healthy subjects.
What is the current status of trial NCT03103646?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2017-03-28. Estimated completion is 2019-07-19.
What interventions are being tested in trial NCT03103646?
The interventions under investigation include: Lu AF35700 (DRUG), Itraconazole (200 mg) (DRUG), Itraconazole (300 mg) (DRUG).
Who is sponsoring clinical trial NCT03103646?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.